- Home
- ITRM vs OMH Comparison
ITRM vs OMH Comparison
Compare ITRM & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- OMH
- Stock Information
- Founded
- ITRM 2015
- OMH 2015
- Country
- ITRM Ireland
- OMH Singapore
- Employees
- ITRM N/A
- OMH N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- OMH Real Estate
- Sector
- ITRM Health Care
- OMH Finance
- Exchange
- ITRM Nasdaq
- OMH Nasdaq
- Market Cap
- ITRM 40.0M
- OMH 35.8M
- IPO Year
- ITRM 2018
- OMH 2023
- Fundamental
- Price
- ITRM $0.76
- OMH $1.15
- Analyst Decision
- ITRM Strong Buy
- OMH Hold
- Analyst Count
- ITRM 2
- OMH 1
- Target Price
- ITRM $7.00
- OMH N/A
- AVG Volume (30 Days)
- ITRM 1.0M
- OMH 258.7K
- Earning Date
- ITRM 08-05-2025
- OMH 09-24-2025
- Dividend Yield
- ITRM N/A
- OMH N/A
- EPS Growth
- ITRM N/A
- OMH N/A
- EPS
- ITRM N/A
- OMH N/A
- Revenue
- ITRM N/A
- OMH $7,976,578.00
- Revenue This Year
- ITRM N/A
- OMH $28.40
- Revenue Next Year
- ITRM $270.19
- OMH $23.07
- P/E Ratio
- ITRM N/A
- OMH N/A
- Revenue Growth
- ITRM N/A
- OMH 117.53
- 52 Week Low
- ITRM $0.66
- OMH $0.59
- 52 Week High
- ITRM $3.02
- OMH $5.46
- Technical
- Relative Strength Index (RSI)
- ITRM 41.71
- OMH 43.74
- Support Level
- ITRM $0.80
- OMH $1.13
- Resistance Level
- ITRM $0.91
- OMH $1.22
- Average True Range (ATR)
- ITRM 0.06
- OMH 0.10
- MACD
- ITRM 0.02
- OMH 0.02
- Stochastic Oscillator
- ITRM 41.08
- OMH 38.89
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.